Haifei Xie, Qilin Tong, Zhinan Xiang, Chenggao Zhou, Luo-Sheng Wan, & Jiachun Chen. (2022). Demethylbellidifolin, a potential aldose reductase inhibitor ameliorates diabetic nephropathy by regulating the polyol pathway. Elsevier.
Chicago Style (17th ed.) CitationHaifei Xie, Qilin Tong, Zhinan Xiang, Chenggao Zhou, Luo-Sheng Wan, and Jiachun Chen. Demethylbellidifolin, a Potential Aldose Reductase Inhibitor Ameliorates Diabetic Nephropathy by Regulating the Polyol Pathway. Elsevier, 2022.
MLA (9th ed.) CitationHaifei Xie, et al. Demethylbellidifolin, a Potential Aldose Reductase Inhibitor Ameliorates Diabetic Nephropathy by Regulating the Polyol Pathway. Elsevier, 2022.
Warning: These citations may not always be 100% accurate.